Reports
United States Compounding Pharmacies Market Size: By Type: Oral, Topical, Suppositories, Others; By Compounding Type: Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Others; By Sterility; By Therapeutic Area; By Distribution Channel; By Application; Competitive Landscape; 2024-2032
United States Compounding Pharmacies Market Outlook
The United States compounding pharmacies market is being driven by the rising geriatric population and growing demand from parenteral division. The market is expected to grow at a CAGR of 6% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Geriatric Population Boosting the Compounding Pharmacies Industry Growth
The rising geriatric demographic base, combined with increased longevity, are the primary drivers of market growth. According to the Population Reference Bureau, by 2060, the geriatric population of the United States is expected to account for about 24% of the total population. The population's longevity has risen as the birth rate has decreased and life expectancy has increased. Additionally, the industry's overall development is supported by compounding pharmacies' low costs over the forecast period. A higher percentage of consumers choose compounding pharmacies, as well as an increasing desire to look healthier and younger, has resulted in increased demand for anti-ageing drugs across the United States, consequently favouring the market growth.
Compounding Pharmacies: Industry Definition and Segmentation
Compounding pharmacies refer to the on-demand distribution of computing resources over the internet, such as storage, servers, applications, and networking, to allow quicker innovation and economies of scale. Customers prefer compounding pharmacies over conventional on-premise deployments because it helps them to pay directly for the resources they need and handle their technology more effectively.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the market is divided into:
- Oral
- Topical
- Suppositories
- Others
With regards to compounding type, the market is segmented into:
- Pharmaceutical Ingredient Alteration (PIA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Others
On the basis of sterility, the market is bifurcated into:
- Sterile
- Non-sterile
By therapeutic area, the market is segregated into:
- Pain and Management
- Hormone Replacement Therapy (HRT)
- Others
Based on distribution channel, the market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
By application, the market is segmented into:
- Pediatric
- Adult
- Geriatric
- Veterinary
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Parenteral Division Fostering the Growth of United States Compounding Pharmacies Industry
The widespread acceptance of compounding pharmacies services, especially public cloud, is expected to boost the market growth of compounding pharmacies in the United States. In 2020, the parenteral division accounted for 18% of the market share of compounding pharmacies in the United States. Compounding ophthalmic treatment drugs, such as glaucoma medications, lower the cost, further boosting the adoption of the product. This has invigorated the market in recent years. Furthermore, compounded dose formulations such as glaucoma reductions assist elderly patients in reducing individual pressure as well as uncertainty about multiple drugs and dosing schedules, thus favouring retail value. Ophthalmic drugs may be administered in a variety of ways, including oral pills, capsules, injections, and drops. As a result, the increasing availability of multiple dosage types in ophthalmic treatment is expected to propel the segment forward. This is predicted to contribute to the overall market growth over the forecast period.
Key Industry Players in the United States Compounding Pharmacies Market
The report gives a detailed analysis of the following key players in the United States compounding pharmacies market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Fagron N.V.
- PharMedium Services, LLC
- Fresenius Kabi Canada
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Compounding Type, Sterility, Therapeutic Area, Distribution Channel, Application |
| Breakup by Type | Oral, Topical, Suppositories, Others |
| Breakup by Compounding Type | Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), Others |
| Breakup by Sterility | Sterile, Non-sterile |
| Breakup by Therapeutic Area | Pain Management, Hormone Replacement Therapy (HRT), Others |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online, Others |
| Breakup by Application | Pediatric, Adult, Geriatric, Veterinary, Others |
| Market Dynamics | SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand and Price |
| Competitive Landscape | Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Fagron N.V., PharMedium Services, LLC, Fresenius Kabi Canada, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 United States
7 Opportunities and Challenges in the Market
8 United States Compounding Pharmacies Market Analysis
8.1 Key Industry Highlights
8.2 United States Compounding Pharmacies Historical Market (2018-2023)
8.3 United States Compounding Pharmacies Market Forecast (2024-2032)
8.4 United States Compounding Pharmacies Market by Type
8.4.1 Oral
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Topical
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Suppositories
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Others
8.5 United States Compounding Pharmacies Market by Compounding Type
8.5.1 Pharmaceutical Ingredient Alteration (PIA)
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Currently Unavailable Pharmaceutical Manufacturing (CUPM)
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Pharmaceutical Dosage Alteration (PDA)
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Others
8.6 United States Compounding Pharmacies Market by Sterility
8.6.1 Sterile
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Non-sterile
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.7 United States Compounding Pharmacies Market by Therapeutic Area
8.7.1 Pain Management
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Hormone Replacement Therapy (HRT)
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Others
8.8 United States Compounding Pharmacies Market by Distribution Channel
8.8.1 Hospital Pharmacies
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Retail Pharmacies
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Online
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Others
8.9 United States Compounding Pharmacies Market by Application
8.9.1 Pediatric
8.9.1.1 Historical Trend (2018-2023)
8.9.1.2 Forecast Trend (2024-2032)
8.9.2 Adult
8.9.2.1 Historical Trend (2018-2023)
8.9.2.2 Forecast Trend (2024-2032)
8.9.3 Geriatric
8.9.3.1 Historical Trend (2018-2023)
8.9.3.2 Forecast Trend (2024-2032)
8.9.4 Veterinary
8.9.4.1 Historical Trend (2018-2023)
8.9.4.2 Forecast Trend (2024-2032)
8.9.5 Others
9 Market Dynamics
9.1 SWOT Analysis
9.1.1 Strengths
9.1.2 Weaknesses
9.1.3 Opportunities
9.1.4 Threats
9.2 Porter’s Five Forces Analysis
9.2.1 Supplier’s Power
9.2.2 Buyer’s Power
9.2.3 Threat of New Entrants
9.2.4 Degree of Rivalry
9.2.5 Threat of Substitutes
9.3 Key Indicators for Demand
9.4 Key Indicators for Price
10 Value Chain Analysis
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Fagron N.V.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 PharMedium Services, LLC
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Fresenius Kabi Canada
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. United States Compounding Pharmacies Market: Key Industry Highlights, 2018 and 2032
2. United States Compounding Pharmacies Historical Market: Breakup by Product (USD Billion), 2018-2023
3. United States Compounding Pharmacies Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. United States Compounding Pharmacies Historical Market: Breakup by Compounding Type (USD Billion), 2018-2023
5. United States Compounding Pharmacies Market Forecast: Breakup by Compounding Type (USD Billion), 2024-2032
6. United States Compounding Pharmacies Historical Market: Breakup by Sterility (USD Billion), 2018-2023
7. United States Compounding Pharmacies Market Forecast: Breakup by Sterility (USD Billion), 2024-2032
8. United States Compounding Pharmacies Historical Market: Breakup by Therapeutic Area (USD Billion), 2018-2023
9. United States Compounding Pharmacies Market Forecast: Breakup by Therapeutic Area (USD Billion), 2024-2032
10. United States Compounding Pharmacies Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
11. United States Compounding Pharmacies Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
12. United States Compounding Pharmacies Historical Market: Breakup by Application (USD Billion), 2018-2023
13. United States Compounding Pharmacies Market Forecast: Breakup by Application (USD Billion), 2024-2032
14. United States Compounding Pharmacies Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 6% between 2024 and 2032.
The major drivers of the market are expansion of compounding pharmacies in the country, increasing prevalence of chronic health conditions, easy handling, and low costs of compounding pharmacies.
The key trends influencing the market include the rising geriatric population, increasing costs of doctor visits, and growing availability of multiple dosage types.
Compounding pharmacies are types of pharmacies that are able to dispense combinations of medications for custom requirements of patients.
The significant applications of compounding pharmacies are pediatric, adult, geriatric, and veterinary, among others.
The major distribution channels in the market are hospital pharmacies, retail pharmacies, and online, among others.
The primary therapeutic areas are pain management, and hormone replacement therapy (HRT), among others.
The various compounding types in the market are pharmaceutical ingredient alteration (PIA), currently unavailable pharmaceutical manufacturing (CUPM), and pharmaceutical dosage alteration (PDA), among others.
Types of compounding pharmacies are oral, topical, and suppositories, among others.
The major players in the United States compounding pharmacies market are Fagron N.V., PharMedium Services, LLC, and Fresenius Kabi Canada, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER